LenioBio’s project has been awarded the STEP Seal by the European Commission. The STEP Seal is granted to proposals deemed strategically important for Europe’s technological and health sovereignty ( ...

The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection successfully met both of its co-primary endpoints, demonstrating that BEYFORTUS provides protection for babies ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Following the FDA ODD, European designation underscores ICT01’s potential as a ...

Medicines derived from living cells — biologics — are some of the most expensive medicines in America. What keeps prices ...

Czech Deputy Health Minister Michaela Matoušková urges the EU to take stronger, proactive steps on pharmaceutical policy, digital health coordination, and equitable access to innovative medicines.

The Breakthrough Therapy Designation (BTD) was granted based on the highly compelling results from the Phase 2 EMBOLD trial in SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) The ...